Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (10547)	10/31/1997 9:43:00 PM
From: Andrew H	Read Replies (1) \| Respond to of 32384

>>I think that the articles will discuss diabetes and Ligand and will help make Ligand a "household name." (Three articles in one week in major publications is very unusual for Ligand or any Biotech its size.<< Sounds very mysterious indeed, Henry. I gues we are not talking Reader's Digest here (:>) You are right that it would be very unusual for a company like LGND to become a household name. Well, I will wait with great anticipation. Hopefully, it will bring the price over 15. (:>) Any more good news and I am afraid of another margin call.